AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6630564 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 80
Study 6630564 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 80
Study 2858618 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid crystal colour thermography
Number of subjects: 80
Study 29678995 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent oxygen saturation monitoring
Number of subjects: 210
Study 29678995 — intervention group
Group type: COMPARATOR
Intervention: Continuous oxygen saturation monitoring
Number of subjects: 210
Study 27077994 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AOT)
Number of subjects: 20
Study 27077994 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - observed pictures showing landscapes
Number of subjects: 20
Study 27077994 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-based brain mapping during AOT
Number of subjects: 20
Study 27077994 — intervention group
Group type: COMPARATOR
Intervention: EEG-based brain mapping
Number of subjects: 20
Study 24687880 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (OnabotA) 150 U
Number of subjects: 0
Study 24687880 — intervention group
Group type: COMPARATOR
Intervention: OnabotulinumtoxinA (OnabotA) 75 U
Number of subjects: 0
Study 24687880 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (OnabotA) 155-195 U
Number of subjects: 0
Study 22427481 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX320 50 mg once daily for 3 days
Number of subjects: 40
Study 22427481 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX320 100 mg once daily for 3 days
Number of subjects: 40
Study 22427481 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX320 200 mg once daily for 3 days
Number of subjects: 40
Study 22427481 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX320 400 mg once daily for 3 days
Number of subjects: 40
Study 22427481 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX320 200 mg twice daily for 3 days
Number of subjects: 40
Study 22427481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 19968614 — intervention group
Group type: EXPERIMENTAL
Intervention: Antireflux stent (Esophageal Z-Stent with Dua antireflux valve; n = 28)
Number of subjects: 65
Study 19968614 — intervention group
Group type: COMPARATOR
Intervention: Conventional stent (Esophageal Z-stent, Ultraflex or Wallstent; n = 37)
Number of subjects: 65
Study 18356253 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral fetal striatal allografts
Number of subjects: 2
Study 15719258 — intervention group
Group type: EXPERIMENTAL
Intervention: beta1Gly49 polymorphism
Number of subjects: 80
Study 15719258 — intervention group
Group type: COMPARATOR
Intervention: other studied polymorphisms
Number of subjects: 80
Study 14656275 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-paclitaxel (TC)
Number of subjects: 0
Study 14656275 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer drugs added to carboplatin-paclitaxel (TC)
Number of subjects: 0
Study 14656275 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-idiotype CA 125 antibodies
Number of subjects: 0
Study 14656275 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidermal growth factor receptor (EGFR) modulation
Number of subjects: 0
Study 10606017 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial ELISA for detecting serum antibody to Neospora caninum
Number of subjects: 1171
Study 10606017 — intervention group
Group type: COMPARATOR
Intervention: Immunofluorescent antibody test (IFAT)
Number of subjects: 1171
Study 8750128 — intervention group
Group type: EXPERIMENTAL
Intervention: Siemens Servo 300 ventilator
Number of subjects: 7
Study 8750128 — intervention group
Group type: COMPARATOR
Intervention: Siemens Servo 900 C ventilator
Number of subjects: 7
Study 8750128 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigger sensitivities of -1 cmH2O, -2 cmH2O, and flow triggering with Siemens Servo 300 ventilator
Number of subjects: 7
Study 8750128 — intervention group
Group type: EXPERIMENTAL
Intervention: Different levels of CPAP with Siemens Servo 300 ventilator
Number of subjects: 7
Study 1850971 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir (2 g/day in three doses for 10 days)
Number of subjects: 9
Study 7327785 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help manual with minimal therapist contact
Number of subjects: 31
Study 7327785 — intervention group
Group type: COMPARATOR
Intervention: Therapist directed training with self-help materials plus 10 individual treatment sessions
Number of subjects: 31
Study 30720582 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS plus OMM
Number of subjects: 218
Study 30720582 — intervention group
Group type: COMPARATOR
Intervention: OMM alone
Number of subjects: 218
Study 28444518 — intervention group
Group type: EXPERIMENTAL
Intervention: Core principles video
Number of subjects: 1123
Study 28444518 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative versions of a video
Number of subjects: 1123
Study 28444518 — intervention group
Group type: COMPARATOR
Intervention: Information-only brochure
Number of subjects: 1123
Study 28444518 — intervention group
Group type: COMPARATOR
Intervention: Information-only video
Number of subjects: 1123
Study 27133225 — intervention group
Group type: EXPERIMENTAL
Intervention: DANCIN intervention (30 minutes/twice-weekly sessions for 12 weeks)
Number of subjects: 10
Study 27133225 — intervention group
Group type: EXPERIMENTAL
Intervention: DANCIN intervention
Number of subjects: 10
Study 24401089 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin/laropiprant
Number of subjects: 25
Study 24401089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 21469244 — intervention group
Group type: EXPERIMENTAL
Intervention: NSLP with Laryngeal Neuromonitoring (LNM)
Number of subjects: 250
Study 21469244 — intervention group
Group type: COMPARATOR
Intervention: NSLP alone
Number of subjects: 250
Study 20420058 — intervention group
Group type: EXPERIMENTAL
Intervention: Grandio (nano-hybrid resin composite)
Number of subjects: 0
Study 20420058 — intervention group
Group type: EXPERIMENTAL
Intervention: Admira (Ormocer)
Number of subjects: 0
Study 20420058 — intervention group
Group type: COMPARATOR
Intervention: Both Grandio and Admira
Number of subjects: 0
Study 18074937 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) guided biopsies
Number of subjects: 30
Study 18074937 — intervention group
Group type: COMPARATOR
Intervention: Random biopsies
Number of subjects: 30
Study 15708031 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of viable bacille Calmette-Guérin (BCG)
Number of subjects: 50
Study 15708031 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified BCG course (three-times-a-week for 3 consecutive weeks)
Number of subjects: 50
Study 15708031 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution)
Number of subjects: 50
Study 15708031 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment with BCG
Number of subjects: 50
Study 10648270 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg Ca/d as calcium carbonate, 5 d/wk for 12 months)
Number of subjects: 160
Study 10648270 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 d/wk for 12 months)
Number of subjects: 160
Study 9309100 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus radiotherapy
Number of subjects: 318
Study 9309100 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 318
Study 8513854 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (PN)
Number of subjects: 8
Study 8513854 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone metasulfobenzoate (PO‐MS)
Number of subjects: 8
Study 8513854 — intervention group
Group type: COMPARATOR
Intervention: Comparison of PN and PO‐MS
Number of subjects: 8
Study 3545718 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g qid)
Number of subjects: 142
Study 3545718 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (400 mg bid)
Number of subjects: 142
Study 3545718 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate and Cimetidine
Number of subjects: 142
Study 31521794 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture (real acupuncture)
Number of subjects: 35
Study 31521794 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture
Number of subjects: 35
Study 31521794 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (manual stimulation of a needle at nonacupuncture points)
Number of subjects: 35
Study 31766273 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg yolk phospholipid drink containing 3 g of phospholipid bound choline
Number of subjects: 18
Study 31766273 — intervention group
Group type: COMPARATOR
Intervention: Control drink with 3 g of choline bitartrate
Number of subjects: 18
Study 31766273 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg yolk phospholipid drink
Number of subjects: 18
Study 31766273 — intervention group
Group type: COMPARATOR
Intervention: Control drink with choline bitartrate
Number of subjects: 18
Study 28653872 — intervention group
Group type: EXPERIMENTAL
Intervention: BML volume in the proximal tibia and distal femur
Number of subjects: 121
Study 28653872 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger medial tibiofemoral BML volume
Number of subjects: 121
Study 28653872 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger lateral tibiofemoral BML volume
Number of subjects: 121
Study 28653872 — intervention group
Group type: EXPERIMENTAL
Intervention: BML volume
Number of subjects: 121
Study 24673380 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of poor residents in a student's neighborhood
Number of subjects: 298
Study 24673380 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of black residents in the neighborhood (for children of single parents)
Number of subjects: 298
Study 23477701 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention including support, empathy, education, and desensitization in the NP group
Number of subjects: 65
Study 23477701 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention including support, empathy, education, and desensitization in the FM group
Number of subjects: 65
Study 23477701 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with no intervention
Number of subjects: 65
Study 21986981 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 25
Study 21986981 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq video laryngoscope
Number of subjects: 25
Study 21986981 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax AWS video laryngoscope
Number of subjects: 25
Study 21986981 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope Ranger video laryngoscope
Number of subjects: 25
Study 21986981 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath Series 5 video laryngoscope
Number of subjects: 25
Study 21986981 — intervention group
Group type: EXPERIMENTAL
Intervention: Storz C-MAC video laryngoscope
Number of subjects: 25
Study 21986981 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq and Ambu Pentax AWS
Number of subjects: 25
Study 19324491 — intervention group
Group type: EXPERIMENTAL
Intervention: Total laparoscopic hysterectomy (TLH)
Number of subjects: 0
Study 16937475 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard triple therapy (20 mg omeprazole b.i.d., 1000 mg amoxicillin b.i.d., 500 mg clarithromycin b.i.d.)
Number of subjects: 360
Study 16937475 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard quadruple therapy (20 mg omeprazole b.i.d., 1000 mg amoxicillin b.i.d., 240 mg colloidal bismuth subcitrate b.i.d., and 500 mg metronidazole b.i.d.)
Number of subjects: 360
Study 16937475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam-based quadruple therapy (375 mg sultamicillin b.i.d.)
Number of subjects: 360
Study 15319615 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewer-administered telephone surveys
Number of subjects: 479
Study 15319615 — intervention group
Group type: COMPARATOR
Intervention: Self-administered mail surveys with telephone reminder calls
Number of subjects: 479
Study 15319615 — intervention group
Group type: COMPARATOR
Intervention: Self-administered mail surveys
Number of subjects: 479
Study 15319615 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modes of survey administration
Number of subjects: 479
Study 11173173 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine tablets
Number of subjects: 58
Study 11173173 — intervention group
Group type: COMPARATOR
Intervention: Oral methadone
Number of subjects: 58
Study 11173173 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 9015032 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG levels in vaginal fluid for normal pregnant women during the first trimester
Number of subjects: 188
Study 9015032 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG levels in vaginal fluid for normal pregnant women during the second trimester
Number of subjects: 188
Study 9015032 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG levels in vaginal fluid for normal pregnant women during the third trimester
Number of subjects: 188
Study 9015032 — intervention group
Group type: COMPARATOR
Intervention: hCG levels in vaginal fluid for women with confirmed PROM
Number of subjects: 188
Study 8328376 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week rehabilitation intervention
Number of subjects: 201
Study 8328376 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 201
Study 3828177 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngoscopy with intubation
Number of subjects: 24
Study 3828177 — intervention group
Group type: COMPARATOR
Intervention: Laryngoscopy only
Number of subjects: 24
Study 3828177 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Laryngoscopy with and without intubation)
Number of subjects: 24
Study 28188570 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey study
Number of subjects: 0
Study 28188570 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized behavioral intervention study
Number of subjects: 0
Study 26268935 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide 50 mg/week (LEF50)
Number of subjects: 244
Study 26268935 — intervention group
Group type: COMPARATOR
Intervention: Leflunomide 10 mg/day (LEF10)
Number of subjects: 244
Study 26632713 — intervention group
Group type: EXPERIMENTAL
Intervention: Semirigid synthetic softcast
Number of subjects: 196
Study 26632713 — intervention group
Group type: COMPARATOR
Intervention: Plaster of Paris (POP) cast
Number of subjects: 196
Study 22727972 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 105
Study 22727972 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 105
Study 22028220 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tPA
Number of subjects: 175
Study 22028220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 18440250 — intervention group
Group type: EXPERIMENTAL
Intervention: Subintimal angioplasty (SA)
Number of subjects: 146
Study 18440250 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 146
Study 16995975 — intervention group
Group type: EXPERIMENTAL
Intervention: ALSS treatment
Number of subjects: 518
Study 12893079 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral neck RT with parotid-sparing techniques
Number of subjects: 93
Study 12893079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral neck RT with parotid-sparing techniques
Number of subjects: 93
Study 12893079 — intervention group
Group type: COMPARATOR
Intervention: Standard three-field technique RT
Number of subjects: 93
Study 12893079 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower radiation dose to contralateral parotid glands
Number of subjects: 93
Study 10860694 — intervention group
Group type: EXPERIMENTAL
Intervention: Connecta Clave(R) (CC(R))
Number of subjects: 173
Study 10860694 — intervention group
Group type: COMPARATOR
Intervention: Control group with standard entry port caps
Number of subjects: 173
Study 7720142 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (GH) 0.2 IU/kg/d
Number of subjects: 18
Study 7720142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2736966 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 16
Study 2736966 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 16
Study 4924346 — intervention group
Group type: EXPERIMENTAL
Intervention: U.K. 2371
Number of subjects: 262
Study 4924346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study 31729933 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus aerobic exercise training (EX)
Number of subjects: 21
Study 31729933 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 21
Study 31729933 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU and EX (both groups)
Number of subjects: 21
Study 31050004 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight and spiral leads using distal electrode
Number of subjects: 795
Study 31050004 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight and spiral leads from at least one of the proximal (E2-E4) electrodes
Number of subjects: 795
Study 31050004 — intervention group
Group type: EXPERIMENTAL
Intervention: Unipolar vectors
Number of subjects: 795
Study 31050004 — intervention group
Group type: COMPARATOR
Intervention: Bipolar vectors
Number of subjects: 795
Study 31050004 — intervention group
Group type: EXPERIMENTAL
Intervention: Capture thresholds
Number of subjects: 795
Study 31050004 — intervention group
Group type: EXPERIMENTAL
Intervention: Capture thresholds over a mean follow-up of 1 year
Number of subjects: 795
Study 29798127 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen 1 mg 2 times/day oral treatment
Number of subjects: 42
Study 29798127 — intervention group
Group type: COMPARATOR
Intervention: Control group treatment (antitussive, expectorant, and inhaled corticosteroids)
Number of subjects: 42
Study 26245802 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 215
Study 26245802 — intervention group
Group type: COMPARATOR
Intervention: PMA-induced NET formation
Number of subjects: 215
Study 26245802 — intervention group
Group type: COMPARATOR
Intervention: CpG-stimulated PDC IFNα generation
Number of subjects: 215
Study 23684588 — intervention group
Group type: EXPERIMENTAL
Intervention: Interstitial brachytherapy (ISBT) combined with interstitial hyperthermia (ISHT)
Number of subjects: 205
Study 23684588 — intervention group
Group type: COMPARATOR
Intervention: Interstitial brachytherapy (ISBT) alone
Number of subjects: 205
Study 21620644 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS)
Number of subjects: 165
Study 21620644 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% oral sucrose
Number of subjects: 165
Study 21620644 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 165
Study 19033369 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix (50-200 mg daily or 100 mg twice daily for 7 days)
Number of subjects: 55
Study 19033369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 19033369 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix (single oral dose of 25-400 mg)
Number of subjects: 55
Study 17690999 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 26
Study 17690999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 15385103 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin 50 mg/m² every 28 days
Number of subjects: 474
Study 15385103 — intervention group
Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m² per day for 5 days every 21 days
Number of subjects: 474
Study 15385103 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin 50 mg/m² every 28 days (for platinum-sensitive disease)
Number of subjects: 474
Study 15385103 — intervention group
Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m² per day for 5 days every 21 days (for platinum-sensitive disease)
Number of subjects: 474
Study 15385103 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin 50 mg/m² every 28 days (for all randomized subjects)
Number of subjects: 474
Study 15385103 — intervention group
Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m² per day for 5 days every 21 days (for all randomized subjects)
Number of subjects: 474
Study 11216984 — intervention group
Group type: EXPERIMENTAL
Intervention: Anomalous origins of the left main coronary artery (ALMCA)
Number of subjects: 2388
Study 11216984 — intervention group
Group type: EXPERIMENTAL
Intervention: Anomalous origins of the right coronary artery (ARCA)
Number of subjects: 2388
Study 11216984 — intervention group
Group type: COMPARATOR
Intervention: Echocardiography
Number of subjects: 2388
Study 11907946 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg E2/0.25 mg NETA
Number of subjects: 119
Study 11907946 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg E2/0.5 mg NETA
Number of subjects: 119
Study 11907946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 7673613 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg once daily for 8 weeks
Number of subjects: 86
Study 7673613 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg once daily for 8 weeks
Number of subjects: 86
Study 7673613 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg once daily for 6 weeks
Number of subjects: 86
Study 7673613 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg once daily for 6 weeks
Number of subjects: 86
Study 2285093 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoprene insoles
Number of subjects: 1388
Study 2285093 — intervention group
Group type: COMPARATOR
Intervention: Control group (no insoles)
Number of subjects: 1388
Study 7447829 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrizamide 280 mg/ml
Number of subjects: 0
Study 7447829 — intervention group
Group type: COMPARATOR
Intervention: Metrizamide 180 mg/ml
Number of subjects: 0